Chinook Therapeutics Inc. (KDNY)
NASDAQ: KDNY
· Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM
Chinook Therapeutics Revenue
Chinook Therapeutics reported an annual revenue of $6.13M, reflecting a -88.13% growth. For the quarter ending June 30, 2023, Chinook Therapeutics generated $1.01M in revenue.
Revenue (ttm)
6.13M
Revenue Growth
-88.13%
Price / Sales Ratio
275.21
Revenue / Employee
28.64K
Employees
214
Market Cap
2.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 6.13M | -88.13% |
| Dec 31, 2021 | 51.63M | +6142.44% |
| Dec 31, 2020 | 827K | -95.21% |
| Dec 31, 2019 | 17.26M | +14.39% |
| Dec 31, 2018 | 15.09M | -12.48% |
| Dec 31, 2017 | 17.24M | -65.99% |
| Dec 31, 2016 | 50.68M | -30.55% |
| Dec 31, 2015 | 72.98M | n/a |